Skip to Content


In the US, Magnevist (gadopentetate dimeglumine systemic) is a member of the drug class magnetic resonance imaging contrast media and is used to treat CNS Magnetic Resonance Imaging and Vascular Magnetic Resonance Imaging.

US matches:

UK matches:

Ingredient matches for Magnevist

Gadopentetic Acid

Gadopentetic Acid is reported as an ingredient of Magnevist in the following countries:

  • Georgia
  • Japan
  • Malta

Gadopentetic Acid dimeglumine (a derivative of Gadopentetic Acid) is reported as an ingredient of Magnevist in the following countries:

  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Bulgaria
  • Canada
  • China
  • Colombia
  • Croatia (Hrvatska)
  • Denmark
  • Ecuador
  • Egypt
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • India
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Myanmar
  • New Zealand
  • Norway
  • Oman
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Slovakia
  • Spain
  • Sweden
  • Tunisia
  • Turkey
  • United Kingdom
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.